Skip to main content

Cambridge Advisors Inc.

Position in NVS — Novartis AG

CIK 1633695 OMAHA, NE

Position in NVS

as of Jun 30, 2026 · filed Jul 16, 2026
Position Value
$1,328,202
-$42,729 QoQ
Shares Held
8,475
-5.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.07%
of 13F equity value
Holder Rank
#544
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Cambridge Advisors Inc. holds $16,674,467 across 6 Drug Manufacturers - General names. NVS ranks #4 (8.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 NVS
Novartis AG
This page
8,475 $1,328,202

All Filings in NVS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,328,202 8,475
2026-03-31 $1,370,931 8,975
2025-12-31 $1,237,383 8,975
2025-09-30 $1,150,954 8,975
2025-06-30 $1,086,064 8,975
2025-03-31 $1,078,569 9,675
2024-12-31 $980,398 10,075
2024-09-30 $1,158,826 10,075
2024-06-30 $1,072,584 10,075
2024-03-31 $974,554 10,075
2023-12-31 $1,087,951 10,775
2023-09-30 $1,097,541 10,775
2023-06-30 $1,087,305 10,775
2023-03-31 $1,076,400 11,700
2022-12-31 $1,065,960 11,750
2022-09-30 $893,117 11,750
2022-06-30 $1,122,135 13,275
2022-03-31 $1,252,631 14,275
2021-12-31 $1,257,381 14,375
2021-09-30 $1,208,299 14,775
2021-06-30 $1,352,633 14,825
2021-03-31 $1,275,789 14,925
2020-12-31 $1,409,367 14,925
2020-09-30 $1,297,878 14,925
2020-06-30 $1,303,549 14,925
2020-03-31 $1,230,566 14,925